<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Access Maced J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Open Access Maced J Med Sci</journal-id><journal-title-group><journal-title>Open Access Macedonian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">1857-9655</issn><publisher><publisher-name>Republic of Macedonia</publisher-name><publisher-loc>ID Design 2012/DOOEL Skopje</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31949538</article-id><article-id pub-id-type="pmc">6953950</article-id><article-id pub-id-type="publisher-id">OAMJMS-7-3319</article-id><article-id pub-id-type="doi">10.3889/oamjms.2019.720</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Management of Severe Acute Pancreatitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Siregar</surname><given-names>Gontar Alamsyah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Siregar</surname><given-names>Ginanda Putra</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia</aff><aff id="aff2"><label>2</label>Department of Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia</aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Gontar Alamsyah Siregar. Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. E-mail: <email xlink:href="gontarsir@gmail.com">gontarsir@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><day>15</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2019</year></pub-date><volume>7</volume><issue>19</issue><fpage>3319</fpage><lpage>3323</lpage><history><date date-type="received"><day>07</day><month>7</month><year>2019</year></date><date date-type="rev-recd"><day>17</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2019 Gontar Alamsyah Siregar, Ginanda Putra Siregar.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC BY-NC/4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)</license-p></license></permissions><abstract><p>Acute pancreatitis is one of the most common causes of hospitalisation from gastrointestinal diseases. The causes of pancreatitis vary between countries. Acute pancreatitis is classified based on Revised Atlanta classification 2013 as mild, moderately severe and severe acute pancreatitis. Acute pancreatic severity can be stratified by scoring systems such as Ranson&#x02019;s score, BISAP score, APACHE-II score, SOFA score. In severe acute pancreatitis, to diagnose, abdominal pain raised amylase or lipase, supported imaging finding and organ failure. Organ failure can be diagnosed by using Modified Marshall Scoring System. Management is started conservatively, which are fluid resuscitation, enteral nutrition, analgesics, and antibiotics. Surgical management is indicated when infected pancreas necrosis is detected. In this review, we will discuss the current management based on recent research.</p></abstract><kwd-group><kwd>Severe acute pancreatitis</kwd><kwd>Management</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Acute pancreatitis is one of the most common causes of hospitalisation from gastrointestinal diseases, with a global incidence ranging from 5-30 cases per 100,000 population per year. In America, pancreatitis causes more than 800,000 hospital visits and costs more than 2.6 billion dollars [<xref rid="ref1" ref-type="bibr">1</xref>].</p><p>The causes of pancreatitis vary between countries. Alcohol is still the dominant disease in Western countries, while in Eastern countries, especially Asia, the most common cause is biliary disease (49-54%) [<xref rid="ref1" ref-type="bibr">1</xref>], [<xref rid="ref2" ref-type="bibr">2</xref>]. Others were caused by drug reactions, pancreatic and cystic malignancies, and hypertriglyceridemia [<xref rid="ref2" ref-type="bibr">2</xref>].</p></sec><sec id="sec1-2"><title>Grading and Severity</title><p>Revised Atlanta classification 2013 are commonly used to categorise acute pancreatitis, which is mild, moderately severe and severe acute pancreatitis. Most of the acute pancreatitis were mild, in which organ failure or complications were not found. In moderately severe acute pancreatitis, Organ failure was transiently found in less than 48 hours [<xref rid="ref3" ref-type="bibr">3</xref>], [<xref rid="ref4" ref-type="bibr">4</xref>], [<xref rid="ref5" ref-type="bibr">5</xref>]. Meanwhile, in severe acute pancreatitis (SAP), organ failure was seen for more than 48 hours. Moderately severe and severe acute pancreatitis manifest in systemic and local complication. The systemic complication in moderately severe acute pancreatitis was seen in chronic renal failure patient who presents with acute symptoms. Local complications usually manifest in the pancreatic and peri-pancreatic fluid collection. Those collections generally appear in the late phase of pancreatitis [<xref rid="ref4" ref-type="bibr">4</xref>].</p><p>Acute pancreatic severity is influenced by organ failure. Revised Atlanta recommend Modified Marshall scoring system as the main tool in determining organ failure [<xref rid="ref4" ref-type="bibr">4</xref>]. Modified Marshall scoring system (<xref rid="T1" ref-type="table">Table 1</xref>) include respiratory, cardiovascular and renal systems score. Score more than 2 of any organs indicate organ failure. Acute pancreatic severity can be stratified by scoring systems such as Ranson&#x02019;s score, BISAP score, APACHE-II score, SOFA score. Ranson&#x02019;s criteria are used within 48 hours of the onset of the attack. APACHE-II score of 9 or more is considered as severe pancreatitis. APACHE score can be observed during the course of acute pancreatitis. The disease is assumed as severe acute pancreatitis when the score is 3 or more. BISAP score is observed during the first 24 hours of admission to predict mortality before the onset of organ failure. BISAP score of more than 3 is related to 5-20% mortality [<xref rid="ref5" ref-type="bibr">5</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Modified Marshall scoring system [<xref rid="ref4" ref-type="bibr">4</xref>]</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">ORGAN SYSTEM</th><th align="center" rowspan="1" colspan="1">0</th><th align="center" rowspan="1" colspan="1">1</th><th align="center" rowspan="1" colspan="1">2</th><th align="center" rowspan="1" colspan="1">3</th><th align="center" rowspan="1" colspan="1">4</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Respiratory PO/FiO<sub>2</sub> (mmHg)</td><td align="center" rowspan="1" colspan="1">&#x0003e; 300</td><td align="center" rowspan="1" colspan="1">226-300</td><td align="center" rowspan="1" colspan="1">151-225</td><td align="center" rowspan="1" colspan="1">76-150</td><td align="center" rowspan="1" colspan="1">&#x02264; 75</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal Serum creatinine (&#x000b5;mol/liter)</td><td align="center" rowspan="1" colspan="1">&#x02264; 100</td><td align="center" rowspan="1" colspan="1">101-200</td><td align="center" rowspan="1" colspan="1">201-350</td><td align="center" rowspan="1" colspan="1">351-500</td><td align="center" rowspan="1" colspan="1">&#x0003e; 500</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic Serum bilirubin (&#x000b5;mol/liter)</td><td align="center" rowspan="1" colspan="1">&#x02264; 20</td><td align="center" rowspan="1" colspan="1">21-60</td><td align="center" rowspan="1" colspan="1">61-120</td><td align="center" rowspan="1" colspan="1">121-240</td><td align="center" rowspan="1" colspan="1">&#x0003e; 240</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiovascular PAR</td><td align="center" rowspan="1" colspan="1">&#x02264; 10,0</td><td align="center" rowspan="1" colspan="1">10,1-15,0</td><td align="center" rowspan="1" colspan="1">15,1-20</td><td align="center" rowspan="1" colspan="1">20,1-30</td><td align="center" rowspan="1" colspan="1">&#x0003e; 30,0</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematologic Platelet / nl</td><td align="center" rowspan="1" colspan="1">&#x0003e; 120</td><td align="center" rowspan="1" colspan="1">81-120</td><td align="center" rowspan="1" colspan="1">51-80</td><td align="center" rowspan="1" colspan="1">21-50</td><td align="center" rowspan="1" colspan="1">&#x02264; 20</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurologic Glassgow coma score</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">13-14</td><td align="center" rowspan="1" colspan="1">10-12</td><td align="center" rowspan="1" colspan="1">7-9</td><td align="center" rowspan="1" colspan="1">&#x02264; 6</td></tr></tbody></table></table-wrap></sec><sec id="sec1-3"><title>Diagnosis</title><p>Revised Atlanta classification requires the presence of abdominal pain, the increment of amylase or lipase more than 3 times upper limit of the normal range, and supported radiographic findings. The abdominal pain characterised by epigastric pain, followed by nausea and vomiting. In physical examination, rebound tenderness, abdominal distention, Cullen&#x02019;s sign, Grey Turner&#x02019;s sign can be found. In severe condition, reduced bowel sound, hypotension can also be found. Pancreatic acinar cell leakage in interstitial space and absorption into circulation cause Increment in amylase and lipase [<xref rid="ref3" ref-type="bibr">3</xref>], [<xref rid="ref4" ref-type="bibr">4</xref>], [<xref rid="ref5" ref-type="bibr">5</xref>]. Contrast-enhanced CT scan (CE-CT scan) is the standard radiographic imaging in detecting acute pancreatitis [<xref rid="ref3" ref-type="bibr">3</xref>], [<xref rid="ref4" ref-type="bibr">4</xref>], [<xref rid="ref5" ref-type="bibr">5</xref>]. In severe acute pancreatitis, CE-CT scan can be used to find pancreatic gland necrosis and the local complications. Pancreatic gland necrosis completely appears in 4 days after the onset of SAP. Before that time, CE-CT scan cannot precisely detect pancreatic necrosis. Other radiographic modalities that were commonly used in diagnosing acute pancreatitis were ultrasonography, MRI. Ultrasonography has a limited role in diagnosing acute pancreatitis, especially in ileus patient. Abundant air volume in the intestine in ileus patient cause difficulty in the visualization of the pancreas. MRI is considered as a good alternative in detecting pancreatic necrosis, pancreatic collection and peri-pancreatic collection. Magnetic resonance cholangiopancreatography (MRCP) can be used as an alternative to ERCP to evaluate pancreatic duct [<xref rid="ref4" ref-type="bibr">4</xref>], [<xref rid="ref5" ref-type="bibr">5</xref>].</p></sec><sec id="sec1-4"><title>Management</title><sec id="sec2-1"><title>Fluid resuscitation</title><p>In severe acute pancreatitis, the patient could have excessive vomiting, reduced oral intake, third space extravasation, respiratory losses, and diaphoresis. Therefore, fluid resuscitation becomes the most important step in managing severe acute pancreatitis [<xref rid="ref6" ref-type="bibr">6</xref>]. It is recommended to be done as early as possible. Crystalloid is the preferred choice in resuscitation. There are many types of research (<xref rid="T2" ref-type="table">Table 2</xref>) showed Ringer Lactate as the replacement fluid has many beneficial effects. The solution has to be given 250-500 ml per hour in the first 12-24 hours. NaCl 0.9% is not recommended since it triggered hyperchloremic metabolic acidosis when it was given in a large volume [<xref rid="ref6" ref-type="bibr">6</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The beneficial effect of Lactated Ringer&#x02019;s solution in various research</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Author</th><th align="left" rowspan="1" colspan="1">Journal, Year</th><th align="left" rowspan="1" colspan="1">Method</th><th align="left" rowspan="1" colspan="1">Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">De &#x02018;Madaria et al., [<xref rid="ref7" ref-type="bibr">7</xref>]</td><td align="left" rowspan="1" colspan="1">United European Gastroenterology Journal, 2018</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Lactated Ringer (LR) is associated with a reduction of CRP levels. LR has an anti-inflammatory effect in patients with acute pancreatitis</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Iqbal et al. [<xref rid="ref8" ref-type="bibr">8</xref>]</td><td align="left" rowspan="1" colspan="1">Journal of Digestive Diseases, 2018</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">LR has anti-inflammatory effects and is associated with decreased risk of persistent SIRS at 24h, which is a marker of severe disease in AP patients</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Choosakul et al. [<xref rid="ref9" ref-type="bibr">9</xref>]</td><td align="left" rowspan="1" colspan="1">Pancreatology, 2018</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">LR solution was superior to NS in SIRS reduction in acute pancreatitis only in the first 24h. But SIRS at 48h and mortality were not different between LR and NS.</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et al. [<xref rid="ref10" ref-type="bibr">10</xref>]</td><td align="left" rowspan="1" colspan="1">Clinical Gastroenterology and Hepatology, 2011</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Patients with acute pancreatitis who were resuscitated with LR solution had reduced systemic inflammation compared with those who received saline.</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RCT (Randomized control trial); CRP (C-reactive protein); SIRS (Systemic inflammatory response syndrome); LR (Lactated Ringer&#x02019;s); NS (Normal saline).</p></fn></table-wrap-foot></table-wrap><p>Few parameters can be used to predict the outcome after fluid resuscitation, which is hematocrit and BUN. Hemoconcentration, which can be seen from hematocrit, develop in the hypovolemic condition in SAP. Hematocrit &#x0003c; 44%-47% is a risk factor for developing necrosis in the pancreas [<xref rid="ref6" ref-type="bibr">6</xref>] Wu et al., revealed that hemoconcentration was related to increment in mortality rate among hospital transferred patients. BUN was also recommended by Wu et al., as a predictor of pancreas necrosis. If fluid resuscitation had been done, BUN was not decreased, then the patient would have increased risk of pancreas necrosis [<xref rid="ref10" ref-type="bibr">10</xref>].</p><p>To monitor the responsiveness of resuscitation, beside BUN and hematocrit, the physician was recommended to monitor urine output. Urine output &#x0003e; 0.5 ml/kg BW/hour was suggested as the target. Lactate was also mentioned as the monitoring parameter. However, there is no evidence to apply this to severe acute pancreatitis [<xref rid="ref6" ref-type="bibr">6</xref>].</p></sec><sec id="sec2-2"><title>Enteral nutrition</title><p>Enteral nutrition was recommended for severe acute pancreatitis over parenteral nutrition due to many beneficial effects as shown by few meta-analysis and trial (<xref rid="T3" ref-type="table">Table 3</xref>). Enteral nutrition may maintain the function and structure of intestinal mucosa [<xref rid="ref5" ref-type="bibr">5</xref>], [<xref rid="ref11" ref-type="bibr">11</xref>]. Enteral nutrition was suggested to be given as early as 48 hours of admission [<xref rid="ref13" ref-type="bibr">13</xref>], [<xref rid="ref11" ref-type="bibr">11</xref>] Early enteral nutrition could reduce mortality, multiple organ failure and infection in comparison with late enteral nutrition and parenteral nutrition [<xref rid="ref12" ref-type="bibr">12</xref>]. Parenteral nutrition was previously recommended as early intervention since it reduces the stimulation of pancreas to secrete enzymes, but it can lead to intestinal atrophy and altered intestinal barrier. As consequences, microorganisms from the gut will translocate to the systemic circulation through damaged intestinal epithelial cells causing sepsis. Furthermore, toxic products and inflammatory mediators also translocate because of increased intestinal permeability in the early stage of severe acute pancreatitis [<xref rid="ref11" ref-type="bibr">11</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of Enteral Nutrition and Total Parenteral Nutrition</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Author</th><th align="left" rowspan="1" colspan="1">Journal, Year</th><th align="left" rowspan="1" colspan="1">Method</th><th align="left" rowspan="1" colspan="1">Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Qi et al. [<xref rid="ref14" ref-type="bibr">14</xref>]</td><td align="left" rowspan="1" colspan="1">Journal of Parenteral and Enteral Nutrition, 2018</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">Comparing early EN to TPN showed a significant reduction in multiple organ failure and pancreatic related infections</td></tr><tr><td align="left" rowspan="1" colspan="1">Vieira et al. [<xref rid="ref15" ref-type="bibr">15</xref>]</td><td align="left" rowspan="1" colspan="1">Acta Cirugica Brasileira, 2010</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">More complications occurred in the parenteral group, although the difference was not statistically significant. Infectious complications were significantly more frequent in the parenteral group (p = 0.006)</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et al. [<xref rid="ref16" ref-type="bibr">16</xref>]</td><td align="left" rowspan="1" colspan="1">Journal of International Medical Research, 2018</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">The duration of hospitalisation was significantly shorter in the EN than TPN group. Compared with TPN, EN had a lower risk of pancreatic infection and organ failure.</td></tr><tr><td align="left" rowspan="1" colspan="1">Yi et al. [<xref rid="ref17" ref-type="bibr">17</xref>]</td><td align="left" rowspan="1" colspan="1">Internal Medicine, 2012</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">TEN was significantly superior to TPN when considering mortality, infectious complications, organ failure</td></tr><tr><td align="left" rowspan="1" colspan="1">Quan et al. [<xref rid="ref18" ref-type="bibr">18</xref>]</td><td align="left" rowspan="1" colspan="1">Clinical Gastroenterology and Hepatology, 2011</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">Compared with TPN, EN was associated with a significantly lower incidence of pancreatic infection complications, MOF, and mortality</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RCT (randomized control trial), EN(enteral nutrition), TPN(total parenteral nutrition, MOF(multiple organ failure), TEN(Total Enteral nutrition).</p></fn></table-wrap-foot></table-wrap><p>In a comparison of nasogastric and nasojejunal feeding, many trials and meta-analysis (<xref rid="T4" ref-type="table">Table 4</xref>) showed no significant difference in mortality, complications and length of stay [<xref rid="ref19" ref-type="bibr">19</xref>]. Nasogastric feeding was cheaper, easy to apply and simpler. Meanwhile, Nasojejunal feeding has to be done by interventional radiologist or endoscopy operator causing a delay in feeding and increment of cost.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison of Nasogastric Feeding and Nasojejunal Feeding</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Author</th><th align="left" rowspan="1" colspan="1">Journal, Year</th><th align="left" rowspan="1" colspan="1">Method</th><th align="left" rowspan="1" colspan="1">Conclusion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Zhu et al. [<xref rid="ref20" ref-type="bibr">20</xref>]</td><td align="left" rowspan="1" colspan="1">Gastroenterology Research and Practice, 2016</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">There were no significant differences in the incidences of mortality, infectious complications, digestive complications, or length of hospital stay between NG and NJ nutrition groups. NG nutrition was as safe and effective as NJ nutrition in with SAP</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Chang et al. [<xref rid="ref21" ref-type="bibr">21</xref>]</td><td align="left" rowspan="1" colspan="1">Critical Care 2013</td><td align="left" rowspan="1" colspan="1">Meta-analysis</td><td align="left" rowspan="1" colspan="1">There were no significant differences in the incidences of mortality between NGT and NJT groups. NG feeding is safe and well-tolerated compared with NJ feeding</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Singh et al. [<xref rid="ref22" ref-type="bibr">22</xref>]</td><td align="left" rowspan="1" colspan="1">Pancreas 2012</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Early enteral feeding through NG was not inferior to NJ in patients with SAP. Infection complications and length of hospital stay were comparable in both groups.</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Kumar et al. [<xref rid="ref23" ref-type="bibr">23</xref>]</td><td align="left" rowspan="1" colspan="1">Journal of Clinical Gastroenterology, 2006</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">Enteral nutrition at a slow infusion is well tolerated by both NJ and NG routes in patients with SAP. Neither NJ nor NG feeding leads to recurrence or worsening of pain in SAP</td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Eatock et al. [<xref rid="ref24" ref-type="bibr">24</xref>]</td><td align="left" rowspan="1" colspan="1">American Journal of Gastroenterology, 2005</td><td align="left" rowspan="1" colspan="1">RCT</td><td align="left" rowspan="1" colspan="1">The simpler, cheaper, and more easily used NG feeding is as good as NJ feeding in patients with objectively graded severe AP</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RCT (randomized control trial); NGT (nasogastric tube); NJ (naso-jejunal); AP (acute pancreatitis).</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-3"><title>Antibiotics</title><p>Many researchers conclude that antibiotics were recommended to be given in severe acute pancreatitis patients who developed sepsis, pancreatic or extrapancreatic infection, infected necrosis systemic inflammatory response [<xref rid="ref25" ref-type="bibr">25</xref>]. Antibiotic as prophylaxis does not decrease mortality and secondary infection significantly [<xref rid="ref5" ref-type="bibr">5</xref>], [<xref rid="ref13" ref-type="bibr">13</xref>]. It is given as prophylaxis when infection marker, such as procalcitonin, IL-6, is detected [<xref rid="ref25" ref-type="bibr">25</xref>]. The recommended antibiotics in treating severe acute pancreatitis that covers gram-positive (Clostridium) and gram-negative (E. coli, Klebsiella, Pseudomonas, Proteus) as well as anaerobes such as imipenem, meropenem, ciprofloxacin, clindamycin and metro-nidazole [<xref rid="ref13" ref-type="bibr">13</xref>], [<xref rid="ref25" ref-type="bibr">25</xref>]. All these antibiotics have adequate penetration and bactericidal effect in infected pancreatic necrosis. Prolong use of antibiotics have a risk of multi drugs resistance and development of fungal infection which is related to a long hospital stay and poor outcome [<xref rid="ref5" ref-type="bibr">5</xref>], [<xref rid="ref25" ref-type="bibr">25</xref>].</p></sec><sec id="sec2-4"><title>Analgesics</title><p>Pain is one of the most complained problems of acute pancreatitis patients. Therefore, pain management needs to be given in the first 24 hours to maintain the patient&#x02019;s quality of life. There are many choices of analgesics, such as fentanyl, meperidine, non-steroid anti-inflammatory drugs. Pain management was based on WHO analgesic ladder which consist of 4 steps (Step 1: NSAID, Step 2: low potent opioid &#x000b1; NSAID &#x000b1; adjuvant drugs, Step 3: High potent opioid &#x000b1; NSAID &#x000b1; adjuvant drugs, Step 4: interventional treatment &#x000b1; high potent opioid &#x000b1; NSAID &#x000b1; adjuvant drugs) [<xref rid="ref27" ref-type="bibr">27</xref>]. Opioids had been reported in the past study as a trigger of spasm of the sphincter of Oddi but in a recent Cochrane review on five RCTs with a total of 227 patients showed no difference between opioids and other analgesic options regarding the risk of complications or clinically serious adverse events [<xref rid="ref26" ref-type="bibr">26</xref>]. A meta-analysis that was made by Stigliano et al. concluded there was no credible evidence to avoid the use of morphine in managing pain in acute pancreatitis [<xref rid="ref28" ref-type="bibr">28</xref>].</p></sec><sec id="sec2-5"><title>Somatostatin and octreotide</title><p>Somatostatin and its long-acting analogue octreotide are the inhibitors of exocrine pancreatic secretion and further prevent the release and activation of enzymes. The benefit of these medica-tions is controversial. W Uhl et al. revealed that octreotide had no benefit in the treatment of acute pancreatitis [<xref rid="ref29" ref-type="bibr">29</xref>]. However, Paran et al., showed that in their study, complication rate was lower in treatment group than in control group (sepsis [24% vs 76%, p &#x0003c; 0.0002], ARDS [28% vs 56%, p = 0.04]). Therefore, they suggested that octreotide might have benefit in the treatment of severe acute pancreatitis [<xref rid="ref30" ref-type="bibr">30</xref>].</p></sec><sec id="sec2-6"><title>Surgical management</title><p>Surgical interventions are indicated when infected necrosis and gallstone obstruction causing biliary pancreatitis is detected. Delayed surgical intervention was suggested because it was related to lower incidences of multi-organ failure, uncontrolled bleeding and sepsis. Therefore, the recommendation is to delay the surgical intervention until the infected necrosis process stops expanding and by the time, the necrotic tissue will liquify. After it liquefies, percutaneous or endoscopic drainage of the infected collection can be ordered. Because of open necrosectomy was associated with high morbidity and mortality, minimally invasive surgical techniques are preferred as the next step of the Step-up approach if drainage by endoscopy failed [<xref rid="ref4" ref-type="bibr">4</xref>]. Step up approach which was started with minimal invasive drainage technique and endoscopic necrosectomy, was concluded by Rasch et al. had significant decrement of morbidity and mortality in necrotising pancreatitis compared to primarily surgical intervention [<xref rid="ref31" ref-type="bibr">31</xref>].</p></sec></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>Severe acute pancreatitis is treated conservatively by fluid resuscitation, early enteral feeding, analgesic, and antibiotic. Ringer lactate is the recommended fluid resuscitation. Enteral feeding as early as 48 hours after admission is the recommended protocol. When dealing with pain, non-opioid and opioid can be used in severe acute pancreatitis. Antibiotics are indicated when infection markers are detected. Somatostatin and it&#x02019;s analogue show no benefit in the treatment of severe acute pancreatitis.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Funding:</bold> This research did not receive any financial support</p></fn><fn fn-type="other"><p><bold>Competing Interests:</bold> The authors have declared that no competing interests exist</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pendharkar</surname><given-names>SA</given-names></name><name><surname>Mathew</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Windsor</surname><given-names>JA</given-names></name><name><surname>Exeter</surname><given-names>J</given-names></name><name><surname>Petrov</surname><given-names>MS</given-names></name></person-group><article-title>Ethnic and geographic of pancreatitis and post- mellitus in New Zealand:a nationwide population- based study</article-title><source>N Z Med J</source><year>2017</year><volume>130</volume><issue>1450</issue><fpage>55</fpage><lpage>68</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name></person-group><article-title>Epidemiology and Etiology of Acute Pancreatitis in Urban and Suburban Areas in Shanghai:A Retrospective Study</article-title><source>Gastroenterol Res Pract</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>8</lpage><comment>https://doi.org/10.1155/2018/1420590 PMid:30158961 PMCid:PMC6109519</comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manrai</surname><given-names>M</given-names></name><name><surname>Kochhar</surname><given-names>R</given-names></name><name><surname>Thandassery</surname><given-names>RB</given-names></name><name><surname>Alfadda</surname><given-names>AA</given-names></name><name><surname>Sinha</surname><given-names>SK</given-names></name></person-group><article-title>The Revised Atlanta Classification of Acute Pancreatitis:A Work Still in Progress?</article-title><source>JOP J Pancreas JOP J Pancreas Jul</source><year>2015</year><volume>16</volume><issue>164</issue><fpage>356</fpage><lpage>64</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>BR</given-names></name><name><surname>Jensen</surname><given-names>KK</given-names></name><name><surname>Bakis</surname><given-names>G</given-names></name><name><surname>Shaaban</surname><given-names>AM</given-names></name><name><surname>Coakley</surname><given-names>FV</given-names></name></person-group><article-title>Revised Atlanta Classification for Acute Pancreatitis:A Pictorial Essay-Erratum</article-title><source>RadioGraphics</source><year>2019</year><volume>39</volume><issue>3</issue><fpage>912</fpage><lpage>912</lpage><comment>https://doi.org/10.1148/rg.2019194003 PMid:31059405</comment></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerem</surname><given-names>E</given-names></name></person-group><article-title>Treatment of severe acute pancreatitis and its complications</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>38</issue><fpage>13879</fpage><lpage>92</lpage><comment>https://doi.org/10.3748/wjg.v20.i38.13879 PMid:25320523 PMCid:PMC4194569</comment><pub-id pub-id-type="pmid">25320523</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Manrai</surname><given-names>M</given-names></name><name><surname>Kochhar</surname><given-names>R</given-names></name></person-group><article-title>Fluid resuscitation in acute pancreatitis</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>48</issue><fpage>18092</fpage><lpage>103</lpage><comment>https://doi.org/10.3748/wjg.v20.i48.18092 PMid:25561779 PMCid:PMC4277949</comment><pub-id pub-id-type="pmid">25561779</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de-Madaria</surname><given-names>E</given-names></name><name><surname>Herrera-Marante</surname><given-names>I</given-names></name><name><surname>Gonz&#x000e1;lez-Camacho</surname><given-names>V</given-names></name><name><surname>Bonjoch</surname><given-names>L</given-names></name><name><surname>Quesada-V&#x000e1;zquez</surname><given-names>N</given-names></name><name><surname>Almenta-Saavedra</surname><given-names>I</given-names></name><etal/></person-group><article-title>Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis:A triple-blind, randomized, controlled trial</article-title><source>United Eur Gastroenterol J</source><year>2018</year><volume>6</volume><issue>1</issue><fpage>63</fpage><lpage>72</lpage><comment>https://doi.org/10.1177/2050640617707864 PMid:29435315 PMCid:PMC5802674</comment></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>U</given-names></name><name><surname>Anwar</surname><given-names>H</given-names></name><name><surname>Scribani</surname><given-names>M</given-names></name></person-group><article-title>Ringer's lactate versus normal saline in acute pancreatitis :systematic review and meta-analysis</article-title><source>J Dig Dis</source><year>2018</year><volume>19</volume><issue>6</issue><fpage>335</fpage><lpage>41</lpage><comment>https://doi.org/10.1111/1751-2980.12606 PMid:29732686</comment><pub-id pub-id-type="pmid">29732686</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choosakul</surname><given-names>S</given-names></name><name><surname>Harinwan</surname><given-names>K</given-names></name><name><surname>Chirapongsathorn</surname><given-names>S</given-names></name><name><surname>Opuchar</surname><given-names>K</given-names></name><name><surname>Sanpajit</surname><given-names>T</given-names></name><name><surname>Piyanirun</surname><given-names>W</given-names></name><name><surname>Puttapitakpong</surname><given-names>C</given-names></name></person-group><article-title>Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial</article-title><source>Pancreatology</source><year>2018</year><fpage>S1424</fpage><lpage>3903</lpage><comment>https://doi.org/10.1016/j.pan.2018.04.016 PMid:29754857</comment></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>BU</given-names></name><name><surname>Hwang</surname><given-names>JQ</given-names></name><name><surname>Gardner</surname><given-names>TH</given-names></name><name><surname>Repas</surname><given-names>K</given-names></name><name><surname>Delee</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Banks</surname><given-names>PA</given-names></name><name><surname>Conwell</surname><given-names>DL</given-names></name></person-group><article-title>Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis</article-title><year>2011</year><volume>9</volume><issue>8</issue><fpage>710</fpage><lpage>17</lpage><comment>https://doi.org/10.1016/j.cgh.2011.04.026 PMid:21645639</comment></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Pei</surname><given-names>L</given-names></name></person-group><article-title>Enteral nutrition provided within 48 hours after admission in severe acute pancreatitis:A systematic review and meta-analysis</article-title><source>Medicine</source><year>2018</year><volume>97</volume><issue>34</issue><fpage>e11871</fpage><comment>https://doi.org/10.1097/MD.0000000000011871 PMid:30142782 PMCid:PMC6112989</comment><pub-id pub-id-type="pmid">30142782</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group><article-title>Enteral nutrition within 48 hours of admission improves clinical outcomes if acute pancreatitis by reducing complications:a meta -analysis</article-title><source>Plos One</source><year>2013</year><volume>8</volume><issue>6</issue><fpage>e64926</fpage><comment>https://doi.org/10.1371/journal.pone.0064926 PMid:23762266 PMCid:PMC3675100</comment><pub-id pub-id-type="pmid">23762266</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>AP</given-names></name><name><surname>Mourad</surname><given-names>MM</given-names></name><name><surname>Bramhall</surname><given-names>SR</given-names></name></person-group><article-title>Acute pancreatitis:current perspectives on diagnosis and management</article-title><source>Dovepress</source><year>2018</year><volume>11</volume><fpage>77</fpage><lpage>85</lpage><comment>https://doi.org/10.2147/JIR.S135751 PMid:29563826 PMCid:PMC5849938</comment></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name></person-group><article-title>Meta-analysis of Early Enteral Nutrition Provided Within 24 hours of Admission on Clinical Outcomes in Acute Pancreatitis</article-title><source>J Parenter Enteral Nutr</source><year>2018</year><volume>42</volume><issue>7</issue><fpage>1139</fpage><lpage>47</lpage><comment>https://doi.org/10.1002/jpen.1139 PMid:29377204</comment></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>JP</given-names></name><name><surname>de Araujo</surname><given-names>GF</given-names></name><name><surname>de Azevedo</surname><given-names>RA</given-names></name><name><surname>Goldenberg</surname><given-names>A</given-names></name><name><surname>Linhares</surname><given-names>MM</given-names></name></person-group><article-title>Parenteral Nutrition versus Enteral Nutrition in Severe Acute Pancreatitis</article-title><source>Acta Cirurgica Brasileira</source><year>2010</year><volume>25</volume><issue>5</issue><fpage>450</fpage><lpage>54</lpage><comment>https://doi.org/10.1590/S0102-&#x021ca;2010000500012 PMid:20&#x0224b;57</comment></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Safety and efficacy of total parenteral nutrition versus total enteral nutrition for patients with severe acute pancreatitis:a meta-analysis</article-title><source>J Int Med Res</source><year>2018</year><volume>46</volume><issue>9</issue><fpage>3948</fpage><lpage>58</lpage><comment>https://doi.org/10.1177/030006051&#x0224e;070 PMid:29962261 PMCid:PMC6136006</comment><pub-id pub-id-type="pmid">29962261</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Ge</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>B</given-names></name></person-group><article-title>Meta-analysis:total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis</article-title><source>Intern Med</source><year>2012</year><volume>51</volume><issue>6</issue><fpage>523</fpage><lpage>30</lpage><comment>https://doi.org/10.2169/internalmedicine.51.6685 PMid:22449657</comment><pub-id pub-id-type="pmid">22449657</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name></person-group><article-title>A Meta-analysis of Enteral Nutrition and Total Parenteral Nutrition in Patients with Acute Pancreatitis</article-title><source>Gastroenterol Res Pract</source><year>2011</year><fpage>698248</fpage><comment>https://doi.org/10.1155/2011/698248 PMid:21687619 PMCid:PMC3113258</comment><pub-id pub-id-type="pmid">21687619</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarnescu</surname><given-names>NO</given-names></name><name><surname>Barbu</surname><given-names>ST</given-names></name><name><surname>Zamescu</surname><given-names>EC</given-names></name><name><surname>Costea</surname><given-names>R</given-names></name><name><surname>Neagu</surname><given-names>S</given-names></name></person-group><article-title>Management of Acute Pancreatitis in Early Stage</article-title><source>Maedica</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>257</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">28261363</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name></person-group><article-title>Nasogastric Nutrition versus Nasojejunal Nutrition in Patients with Severe Acute Pancreatitis:A Meta-Analysis of Randomized Controlled Trials</article-title><source>Gastroenterol Res Pract</source><year>2016</year><fpage>1</fpage><lpage>8</lpage><comment>https://doi.org/10.1155/2016/6430632 PMid:27340401 PMCid:PMC4909901</comment></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YS</given-names></name><name><surname>Fu</surname><given-names>HQ</given-names></name><name><surname>Xiao</surname><given-names>YM</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name></person-group><article-title>Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis:a meta-analysis</article-title><source>Crit Care</source><year>2013</year><volume>17</volume><fpage>R118</fpage><comment>https://doi.org/10.1186/cc12790 PMid:23786708 PMCid:PMC4057382</comment><pub-id pub-id-type="pmid">23786708</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>B</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Sachdev</surname><given-names>V</given-names></name><name><surname>Bhardwaj</surname><given-names>P</given-names></name><name><surname>Mani</surname><given-names>K</given-names></name><name><surname>Joshi</surname><given-names>YK</given-names></name><name><surname>Saraya</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis:a noninferiority randomized controlled trial</article-title><source>Pancreas</source><year>2012</year><volume>41</volume><issue>1</issue><fpage>153</fpage><lpage>9</lpage><comment>https://doi.org/10.1097/MPA.0b013e318221c4a8 PMid:21775915</comment><pub-id pub-id-type="pmid">21775915</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Saraya</surname><given-names>A</given-names></name><name><surname>Joshi</surname><given-names>YK</given-names></name></person-group><article-title>Early enteral nutrition in severe acute pancreatitis:a prospective randomized controlled trial comparing nasojejunal and nasogastric routes</article-title><source>J Clin Gastroenterol</source><year>2006</year><volume>40</volume><issue>5</issue><fpage>431</fpage><lpage>4</lpage><comment>https://doi.org/10.1097/00004836-200605000-00013 PMid:16721226</comment><pub-id pub-id-type="pmid">16721226</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eatoc</surname><given-names>FC</given-names></name><name><surname>Chong</surname><given-names>P</given-names></name><name><surname>Menezes</surname><given-names>N</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>McKay</surname><given-names>CJ</given-names></name><name><surname>Carter</surname><given-names>CR</given-names></name><name><surname>Imrie</surname><given-names>CW</given-names></name></person-group><article-title>A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis</article-title><source>Am J Gastroenterol</source><year>2005</year><volume>100</volume><issue>2</issue><fpage>432</fpage><lpage>9</lpage><comment>https://doi.org/10.1111/j.1572-0241.2005.40587.x PMid:15667504</comment><pub-id pub-id-type="pmid">15667504</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourad</surname><given-names>MM</given-names></name><name><surname>Evans</surname><given-names>RPT</given-names></name><name><surname>Kalidindi</surname><given-names>V</given-names></name><name><surname>Navaratnam</surname><given-names>R</given-names></name><name><surname>Dyorkin</surname><given-names>L</given-names></name><name><surname>Bramhall</surname><given-names>SR</given-names></name></person-group><article-title>Prophylactic antibiotics in acute pancreatitis:endless debate</article-title><source>Ann R Surg Engl</source><year>2017</year><volume>99</volume><issue>2</issue><fpage>107</fpage><lpage>112</lpage><comment>https://doi.org/10.1308/rcsann.2016.0355 PMid:27917667 PMCid:PMC5392851</comment></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basurto</surname><given-names>Ona X</given-names></name><name><surname>Rigau</surname><given-names>Comas D</given-names></name><name><surname>Urrutia</surname><given-names>G</given-names></name></person-group><article-title>Opioids for acute pancreatitis pain</article-title><source>Cochrane Database Syst Rev</source><year>2013</year><volume>7</volume><fpage>CD009179</fpage><comment>https://doi.org/10.1002/14651858.CD009179.pub2</comment></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schorn</surname><given-names>S</given-names></name><name><surname>Ceyhan</surname><given-names>GO</given-names></name><name><surname>Tieftrunk</surname><given-names>E</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Demir</surname><given-names>IE</given-names></name></person-group><article-title>Pain management in acute pancreatitis</article-title><source>Pancreapedia:Exocrine Pancreas Knowledge Base</source><year>2015</year></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stigliano</surname><given-names>S</given-names></name><name><surname>Sternby</surname><given-names>H</given-names></name><name><surname>Madaria</surname><given-names>E</given-names></name><name><surname>Capurso</surname><given-names>G</given-names></name><name><surname>Petrov</surname><given-names>MS</given-names></name></person-group><article-title>Early management of acute pancreatitis:A review of best evidence</article-title><source>Digestive and Liver Disease</source><year>2017</year><volume>49</volume><fpage>585</fpage><lpage>94</lpage><comment>https://doi.org/10.1016/j.dld.2017.01.168 PMid:28262458</comment><pub-id pub-id-type="pmid">28262458</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhl</surname><given-names>W</given-names></name><name><surname>Buchler</surname><given-names>M</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Beger</surname><given-names>H</given-names></name><name><surname>Adler</surname><given-names>G</given-names></name><name><surname>Gaus</surname><given-names>W</given-names></name><name><surname>The</surname><given-names>G</given-names></name></person-group><article-title>A randomised, double blind, multicenter trial of octreotide in moderate to severe acute pancreatitis</article-title><source>Gut</source><year>1999</year><volume>45</volume><issue>1</issue><fpage>97</fpage><lpage>104</lpage><comment>https://doi.org/10.1136/gut.45.1.97 PMid:10369711 PMCid:PMC1727562</comment><pub-id pub-id-type="pmid">10369711</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paran</surname><given-names>H</given-names></name><name><surname>Mayo</surname><given-names>A</given-names></name><name><surname>Paran</surname><given-names>D</given-names></name><name><surname>Neufeld</surname><given-names>D</given-names></name></person-group><article-title>Octreotide treatment inpatients with severe acute pancreatitis</article-title><source>Digestive diseases and sciences</source><year>2000</year><volume>45</volume><issue>11</issue><fpage>2247</fpage><lpage>51</lpage><comment>https://doi.org/10.1023/A:1026679106463 PMid:11215748</comment><pub-id pub-id-type="pmid">11215748</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasch</surname><given-names>S</given-names></name><name><surname>Phillip</surname><given-names>V</given-names></name><name><surname>Reichel</surname><given-names>S</given-names></name><name><surname>Rau</surname><given-names>B</given-names></name><name><surname>Zapf</surname><given-names>C</given-names></name><name><surname>Rosenahl</surname><given-names>J</given-names></name><etal/></person-group><article-title>Open surgical versus minimal invasive necrosectomy of pancreas- a retrospective multicenter analysis of The German Pancreatitis Study</article-title><source>Plos One</source><year>2016</year><volume>11</volume><issue>9</issue><fpage>e0163651</fpage><comment>https://doi.org/10.1371/journal.pone.0163651 PMid:2766&#x0222a;PMCid:PMC5036800</comment><pub-id pub-id-type="pmid">27668746</pub-id></element-citation></ref></ref-list></back></article>